Orthobiologics for Personal Injury Recovery Plans

Abstract

Welcome to our educational series. I am Dr. Alex Jimenez, and today, we explore the sophisticated and rapidly evolving world of orthobiologics. Drawing on the latest insights from leading researchers, we will explore the critical nuances of Platelet-Rich Plasma (PRP) formulations, specifically the debate between leukocyte-rich and leukocyte-poor preparations and their implications for joint health. We will explore advanced therapies, such as micro-fragmented adipose tissue, and dissect the significance of addressing subchondral bone pathology in treating osteoarthritis. This post aims to provide a clear, evidence-based roadmap for understanding these powerful regenerative tools. We’ll discuss patient selection, procedural considerations, and the importance of a comprehensive, integrative approach that combines these advanced biologics with foundational care, such as chiropractic, rehabilitation, and functional medicine, to optimize patient outcomes.

Our Integrative Approach: A Collaboration for Comprehensive Care

At Injury Medical Clinic PA, we pride ourselves on a multidisciplinary, integrative framework that provides the most comprehensive care for our patients. I am Dr. Alex Jimenez, and my background in chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP) allows me to view patient health through a holistic lens.

To elevate our standard of care, we are honored to have Dr. Maria Guadalupe Cardenas, MD, as our Medical Director and Collaborative Physician. Dr. Cardenas is Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) and brings over 40 years of invaluable experience as an internist. Her medical oversight is a cornerstone of our practice, ensuring that every treatment plan, especially those involving advanced medical procedures and orthobiologics, is safe, effective, and medically sound.

This collaborative model is particularly crucial in the context of personal injury and complex musculoskeletal conditions. Our team seamlessly integrates:

• Medical Oversight (Dr. Cardenas): Providing diagnostic leadership, medical management, and ensuring all procedures adhere to the highest medical standards.
• Chiropractic Care (Dr. Jimenez): Focusing on spinal and joint biomechanics, nervous system function, and structural integrity. Correcting misalignments and restoring proper movement patterns are fundamental to healing.
• Functional Medicine: Investigating the root causes of inflammation and dysfunction, such as metabolic, nutritional, and environmental factors.
• Rehabilitation & Physical Therapy: Developing targeted exercise programs to restore strength, flexibility, and function.
• Orthobiologics: Utilizing the body’s own healing mechanisms through advanced regenerative therapies.

By combining Dr. Cardenas’s internal medicine expertise with my chiropractic and functional medicine background, we can address the patient from every angle. A patient with knee osteoarthritis, for example, not only receives an advanced biologic injection under medical supervision but also benefits from chiropractic adjustments to correct biomechanical imbalances that contribute to knee strain, functional medicine to manage systemic inflammation, and a rehabilitation plan to strengthen the supporting musculature. This synergy is the future of patient-centered care.

The Great Debate: Understanding Leukocytes in Platelet-Rich Plasma (PRP)

As a practitioner deeply immersed in the world of orthobiologics, I find the ongoing discussions about the composition of Platelet-Rich Plasma (PRP) to be absolutely essential. One of the most critical parameters is the concentration of white blood cells (leukocytes) in a PRP preparation.

When we create PRP, we concentrate platelets from a patient’s own blood. However, the process also concentrates other cells, including leukocytes. The central question becomes: which leukocytes do we want, and at what concentration?

• Leukocyte-Rich vs. Leukocyte-Poor PRP: Historically, the term “leukocyte-rich” often referred to PRP with high neutrophil counts. Neutrophils are a type of white blood cell that act as first responders to acute injury or infection. While crucial in that context, we now understand that injecting a high concentration of neutrophils into a joint with chronic osteoarthritis can be problematic. These cells release pro-inflammatory cytokines and enzymes that can potentially cause a painful flare-up and may even be detrimental to cartilage cells (chondrocytes).
• The Importance of the Differential: The conversation has become more sophisticated. It’s not just about the total white blood cell count; it’s about the differential—the specific types of white blood cells present. Modern research, particularly European studies, highlights the potential benefits of a PRP formulation that is poor in neutrophils but rich in monocytes and lymphocytes. Monocytes are precursors to macrophages, which can play a powerful role in modulating inflammation and coordinating tissue repair. Therefore, the ideal formulation for intra-articular (in-joint) injections appears to be neutrophil-poor yet may still contain beneficial mononuclear cells.
• Know Your System: This is a crucial take-home point for any practitioner or patient. The final composition of PRP depends heavily on the preparation system used—the centrifuge, the kit, and the specific protocol (e.g., how many spins, at what speed). Not all “PRP” is the same. I always advise asking the provider or the manufacturer for data, whether from white papers or peer-reviewed studies, that details the cellular composition their system produces. Does it create a high-neutrophil or low-neutrophil concentrate? What are the typical monocyte and platelet concentrations? Without this information, you are flying blind.

My clinical observation aligns with this evidence. Injecting a neutrophil-rich PRP into an osteoarthritic knee can lead to unhappy patients with significant post-injection pain and swelling. Conversely, using a carefully prepared, leukocyte-poor (specifically neutrophil-poor) PRP often yields better results with a lower inflammatory response. The goal is to stimulate healing, not to create an intense inflammatory storm inside the joint (Philippe et al., 2016).

Advanced Biologics: Micro-Fragmented Adipose Tissue

When PRP or other first-line treatments are not providing the desired relief, we may consider more advanced options. One such therapy is using micro-fragmented adipose tissue. This procedure involves harvesting a small amount of a patient’s fat (adipose) tissue, typically from the flank or abdomen, and processing it to create an injectable that is rich in regenerative cells.

Why Use Adipose Tissue?

Fat tissue is an incredible reservoir of cells that support healing and regeneration. It contains a high concentration of mesenchymal stem cells (MSCs) and other crucial cells, such as pericytes, which reside around blood vessels. When micro-fragmented, the resulting product provides not just cells but also the structural micro-environment—the “scaffolding”—that these cells need to thrive and orchestrate tissue repair.

Patient Selection and Procedure

I typically reserve this option for specific cases:

1. Patients with Moderate to Severe Osteoarthritis: Especially those who have not responded to other treatments and are trying to avoid or delay joint replacement surgery.
2. Post-Surgical Patients: Individuals who want to augment a surgical repair with a biologic boost to enhance healing.
3. Patients with Persistent Joint Effusions (Swelling): When other methods have failed to control chronic inflammation and fluid buildup.

The harvesting procedure itself is remarkably well-tolerated. It is most often performed in a clinical procedure room while the patient is awake, using a local anesthetic and a tumescent technique. This involves infusing the fat tissue with a saline solution containing a local anesthetic (like lidocaine) and epinephrine. This not only numbs the area but also makes the fat easier to harvest. Compelling data from the plastic surgery field shows that liposuction performed on an awake patient is significantly safer than when done under general anesthesia.

A key procedural pearl is patience. After infusing the tumescent solution, it is vital to wait at least 20-30 minutes before harvesting. This allows the anesthetic to work fully and the tissue to become optimally prepared, making the harvest smoother and more comfortable for the patient. In our clinic, we use this time efficiently, allowing me to see other patients while the solution takes effect. Patients are often pleasantly surprised by how comfortable the experience is.

The Foundation of the Joint: Treating the Subchondral Bone

One of the most significant paradigm shifts in treating osteoarthritis is the growing recognition that it is not just a disease of the cartilage; it is a disease of the entire joint organ, including the subchondral bone—the layer of bone just beneath the cartilage.

In a healthy joint, the subchondral bone acts as a shock absorber. In osteoarthritis, this bone can become damaged, developing bone marrow lesions, which are essentially areas of stress, inflammation, and swelling within the bone. These lesions are strongly associated with joint pain and disease progression. Think of it like a house built on a cracked and unstable foundation. No matter how many times you repair the walls (the cartilage), the house will remain unstable until you fix the foundation (the subchondral bone).

Subchondral Injection Procedures

Pioneering work, particularly by researchers in France, has explored the direct injection of biologics into the subchondral bone. A landmark study by Hernigou et al. (2014) showed incredible long-term results—a 95% avoidance of knee arthroplasty at 15 years—by injecting bone marrow concentrate into the subchondral bone of patients with knee osteoarthritis.

The mechanism is likely twofold:

1. Decompression: The simple act of drilling a needle into the high-pressure environment of a bone marrow lesion can decompress it, providing immediate pain relief. This is similar to the concept of intraosseous hypertension, where elevated pressure within the bone contributes to pain.
2. Biologic Augmentation: Introducing regenerative cells (such as those from bone marrow or calcium phosphate cement) into this environment may help heal the “sick” bone and restore its structural integrity.

While these results are impressive, it’s important to maintain a balanced perspective. Across the broader literature on subchondral procedures, there is a consistent 20% failure rate. This means that while 80% of patients may do very well, a significant portion will still progress and may require further intervention.

The Chiropractic and Integrative Perspective: Modifying the Environment

This brings me to a core principle of my practice: there is limited magic in the needle. The success of any orthobiologic procedure is profoundly influenced by how we modify the patient’s overall biomechanical and biochemical environment.

This is where integrative chiropractic care becomes indispensable.

• Biomechanical Offloading: If a patient has varus malalignment (bow-leggedness) that is placing excessive compressive force on the medial (inner) part of their knee, no amount of injected biologics will be effective long-term if that mechanical stress is not addressed. As a chiropractor, I assess and correct imbalances in the pelvis, spine, and lower extremities that contribute to faulty knee mechanics. We can also use tools like offloading braces to mechanically shift pressure away from the damaged part of the joint.
• Neuromuscular Re-education: Weak quadriceps or gluteal muscles force the knee joint to absorb more impact. Our rehabilitation programs focus on strengthening these key supporting muscles, effectively creating a “muscular brace” for the joint.
• Addressing Systemic Factors: From a functional medicine standpoint, we must ask: Why is this patient’s joint environment so inflammatory? We investigate and address factors such as a pro-inflammatory diet, poor gut health, metabolic dysfunction (such as insulin resistance), and nutrient deficiencies that can fuel chronic inflammation and inhibit healing. Weight loss, for example, is one of the most powerful interventions for reducing mechanical load and systemic inflammation.

In my experience, the patients who achieve the best and most durable outcomes are those who combine an advanced biologic procedure with a comprehensive plan to modify these underlying factors. We treat the soil, not just the plant. The patients in the 20% failure group are often those who cannot or will not address the foundational issues of mechanical overload and systemic inflammation. By integrating chiropractic care, targeted rehabilitation, and functional medicine, we give the powerful biologics we inject the best possible chance to succeed.

References

• Hernigou, P., Bouthors, C., Bastard, C., Flouzat Lachaniette, C. H., Rouard, H., & Dubory, A. (2014). Subchondral bone marrow concentrate injection is a better treatment than knee arthroplasty for osteonecrosis of the knee in patients younger than 60 years of age: a 15-year prospective controlled study. International Orthopaedics, 38(8), 1709–1718.* https://doi.org/10.1007/s00264-014-2394-5
• Philippe, H., Charles, B., Cédric, B., Charlotte, H. F. L., Hélène, R., & Arnaud, D. (2016). Does the injection of bone marrow concentrate cells into a knee with osteonecrosis improve the clinical outcome of a high tibial osteotomy? A matched-pair controlled study. International Orthopaedics, 40(8), 1611–1618.* https://doi.org/10.1007/s00264-015-3075-8